Analysts Offer Insights on Healthcare Companies: Insulet Corp (NASDAQ: PODD) and Varian Medical Systems (NYSE: VAR)

By Austin Angelo

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Insulet Corp (NASDAQ: PODD) and Varian Medical Systems (NYSE: VAR) with bullish sentiments.

Insulet Corp (NASDAQ: PODD)

In a report issued on June 12, Raj Denhoy from Jefferies reiterated a Buy rating on Insulet Corp (NASDAQ: PODD), with a price target of $48. The company’s shares closed yesterday at $46.77, close to its 52-week high of $48.23.

According to TipRanks.com, Denhoy is a top 100 analyst with an average return of 16.6% and a 74.2% success rate. Denhoy covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Zimmer Biomet Holdings, and Varian Medical Systems.

Insulet Corp has an analyst consensus of Moderate Buy, with a price target consensus of $46.67.

Varian Medical Systems (NYSE: VAR)

In a report issued on June 12, Biren Amin from Jefferies reiterated a Buy rating on Varian Medical Systems (NYSE: VAR), with a price target of $110. The company’s shares closed yesterday at $102.67, close to its 52-week high of $103.79.

According to TipRanks.com, Amin is a 3-star analyst with an average return of 1.9% and a 44.6% success rate. Amin covers the Healthcare sector, focusing on stocks such as DBV Technologies SA – American, Stemline Therapeutics Inc, and Lion Biotechnologies Inc.

Varian Medical Systems has an analyst consensus of Moderate Buy, with a price target consensus of $102.33.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.